CLASS II Drug recall · Reported 20 Jul 2022 · FDA Enforcement Report

Draximage MAA (Kit for the preparation of Technnetium Tc recalled

Jubilant Draximage is recalling Draximage MAA (Kit for the preparation of Technnetium Tc 99m Albumin Aggregate) 2.5 mg, distributed nationwide in the US. The recall was initiated on 16 Jun 2022 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesLot # 1H005, exp. date Nov 30, 2023
NDC65174-270
Quantity recalled519 cartons/30 vials each

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

Recall details

Recall number
D-1189-2022
FDA event ID
90455
Recalling firm
Jubilant Draximage, Kirkland
Manufacturer
Jubilant DraxImage Inc
Classification
Class II
Status
Terminated
Recall initiated
16 Jun 2022
FDA classified
8 Jul 2022
Reported
20 Jul 2022
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Sterility

Timeline

16 Jun 2022Recall initiated by company
8 Jul 2022Classified by FDA+22 days
20 Jul 2022Published in enforcement report+12 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Lack of Assurance of Sterility: Out-of-specification test results obtained for Endotoxin testing.

A sterility recall means a product that must be sterile, such as an injection or eye drop, may be contaminated. Using a non-sterile product can cause serious infection.

Product as listed by the FDA

Draximage MAA (Kit for the preparation of Technnetium Tc 99m Albumin Aggregate) 2.5 mg per vial, 30 glass vials per carton, Rx Only, Manufactured for Jubilant Draximage Inc. Kirkland, Canada, NDC 65174-270-30.

Where it was distributed

Product was distributed to retailers nationwide.

Nationwide

Stores named: Costco

Questions about this recall

Why was it recalled?

Lack of Assurance of Sterility: Out-of-specification test results obtained for Endotoxin testing.

Which lots are affected?

Lot # 1H005, exp. date Nov 30, 2023

Where was it sold?

Product was distributed to retailers nationwide.

What should I do if I have it?

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Jubilant Draximage

All 3
ReportedClassRecallCompanyReasonWhere
DrugCLASS IIDraximage Dtpa (Kit For The Preparation OF Technetium TC recalledJubilant DraximagePotency & AssayNationwide
DrugCLASS IIISodium Iodide I, USP Diagnostic Oral recalled by Jubilant DraximageSodium Iodide I 131 DiagnosticJubilant DraximageOtherNationwide